We are live on
!
Find out more
VAIA
Virtus Alternative Investment Advisers Portfolio holdings
AUM
$6.71M
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
+28.13%
1 Year Est. Return
+36.98%
3 Year Est. Return
+42.83%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.41M
AUM Growth
-$894K
(-12%)
Cap. Flow
-$2.23M
Cap. Flow
% of AUM
-34.82%
Top 10 Holdings %
Top 10 Hldgs %
17.91%
Holding
299
New
68
Increased
3
Reduced
201
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$151K |
| 2 |
Lumentum
LITE
|
+$90.8K |
| 3 |
Qorvo
QRVO
|
+$82K |
| 4 |
Broadcom
AVGO
|
+$81.7K |
| 5 |
Qualcomm
QCOM
|
+$81.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$820K |
| 2 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$787K |
| 3 |
Equifax
EFX
|
+$93.8K |
| 4 |
RTX Corp
RTX
|
+$62K |
| 5 |
TransUnion
TRU
|
+$60.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.47% |
| 2 | Industrials | 20.95% |
| 3 | Healthcare | 18.94% |
| 4 | Communication Services | 9.16% |
| 5 | Consumer Staples | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Viking Therapeutics
VKTX
$4.02B
| $18K | 0.28% |
+2,521
| New | +$16.7K |
|
77
West Pharmaceutical
WST
$24.8B
| $18K | 0.28% |
78
-74
| -49% | -$14.5K |
|
78
AppFolio
APPF
$7.07B
| $17K | 0.27% |
107
-100
| -48% | -$13.1K |
|
79
AtriCure
ATRC
$2.12B
| $17K | 0.27% |
370
-346
| -48% | -$15.1K |
|
80
AeroVironment
AVAV
$9.57B
| $17K | 0.27% |
+213
| New | +$13.7K |
|
81
BioMarin Pharmaceuticals
BMRN
$13.3B
| $17K | 0.27% |
140
-132
| -49% | -$13.1K |
|
82
Cadence Design Systems
CDNS
$91.4B
| $17K | 0.27% |
176
-165
| -48% | -$13.8K |
|
83
Corcept Therapeutics
CORT
$12.3B
| $17K | 0.27% |
+990
| New | +$13.9K |
|
84
Cintas
CTAS
$81.1B
| $17K | 0.27% |
256
-240
| -48% | -$13.9K |
|
85
Deckers Outdoor
DECK
$13.3B
| $17K | 0.27% |
510
-480
| -48% | -$13.2K |
|
86
DexCom
DXCM
$33.1B
| $17K | 0.27% |
168
-160
| -49% | -$14.3K |
|
87
National Beverage
FIZZ
$2.91B
| $17K | 0.27% |
+548
| New | +$14.8K |
|
88
Halozyme
HALO
$12.2B
| $17K | 0.27% |
632
-592
| -48% | -$13.4K |
|
89
Incyte
INCY
$24.6B
| $17K | 0.27% |
163
-153
| -48% | -$14.8K |
|
90
Inspire Medical Systems
INSP
$1.73B
| $17K | 0.27% |
197
-184
| -48% | -$14.1K |
|
91
IPG Photonics
IPGP
$3.61B
| $17K | 0.27% |
104
-97
| -48% | -$13.8K |
|
92
Monolithic Power Systems
MPWR
$67.9B
| $17K | 0.27% |
70
-65
| -48% | -$13.2K |
|
93
Protolabs
PRLB
$2.14B
| $17K | 0.27% |
152
-142
| -48% | -$14.6K |
|
94
Tandem Diabetes Care
TNDM
$1.59B
| $17K | 0.27% |
+168
| New | +$13.4K |
|
95
Trex
TREX
$4.91B
| $17K | 0.27% |
260
-244
| -48% | -$13K |
|
|
MRTX
96
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $17K | 0.27% |
+146
| New | +$14.2K |
|
|
SGEN
97
DELISTED
Seagen Inc. Common Stock
SGEN
| $17K | 0.27% |
100
-92
| -48% | -$13.7K |
|
|
TPTX
98
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $17K | 0.27% |
261
-244
| -48% | -$14.1K |
|
|
ARNA
99
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $17K | 0.27% |
268
-255
| -49% | -$14K |
|
100
Alnylam Pharmaceuticals
ALNY
$29B
| $16K | 0.25% |
107
-101
| -49% | -$13.6K |
|
Similar funds
SAM
AIDCT
FPC
RC
NCM
GBA
GFWEX
HAM
Virtus Alternative Investment Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, Virtus Alternative Investment Advisers held 299 positions worth $6.41M, down 12% from $7.3M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Virtus Alternative Investment Advisers withdrew a net $2.23M in Q2 2020, closing 23 positions and reducing 201 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $820K position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Virtus Alternative Investment Advisers opened a new position in Otis Worldwide worth $165K.
- Virtus Alternative Investment Advisers's largest Q2 2020 buy was Otis Worldwide: 2,908 shares worth $165K.
- Virtus Alternative Investment Advisers added most to Skyworks Solutions in Q2 2020, an estimated $65.2K increase.
- Virtus Alternative Investment Advisers's biggest Q2 2020 reduction was Equifax, cutting an estimated $93.8K.
- Virtus Alternative Investment Advisers fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2020, selling an estimated $820K.
- Virtus Alternative Investment Advisers's ten largest holdings make up 18% of its $6.41M portfolio in Q2 2020.
- Virtus Alternative Investment Advisers opened 68 new positions and closed 23 in Q2 2020.
- Virtus Alternative Investment Advisers's portfolio value fell 12% quarter-over-quarter to $6.41M.
Based on Virtus Alternative Investment Advisers's 13F filing for Q2 2020, filed 5 Aug 2020.